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Intravenous infusion of basic amino acids is used
experimentally and pharmacologically to prevent renal
proximal tubular uptake of filtered proteins. Intravenously
injected L-lysine is rapidly cleared from plasma and the effect
on tubular protein reabsorption is transient. To obtain a
more sustained effect, we developed a model of oral L-lysine
administration and characterized this model by analyzing
urinary protein excretion and proximal tubule uptake of
filtered proteins. Rats placed in metabolic cages were treated
with 20 mmol/kg/6 h of L-lysine, glycine, or water.
Urines were analyzed for proteins by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis, immunoblotting,
and radioimmunoassay. Proximal tubule uptake of proteins
and expression of apical membrane receptors were
investigated by immunocytochemistry. In vitro uptake and
receptor expression were studied using a yolk sac cell line.
L-lysine administration produced increased urinary excretion
of a large number of proteins while the effect on tubular
accumulation of selected proteins was variable. L-lysine
treatment induced changes in the localization of two
receptors responsible for tubular endocytosis of filtered
proteins. In conclusion, oral L-lysine treatment induced
proteinuria, in particular albuminuria, as efficiently as
previous reports on intravenous infusion. The effect on
tubular protein accumulation was variable suggesting
differential effects on tubular reabsorption and degradation
of filtered proteins. Changes in tubular protein handling were
accompanied by changes in the localization of the endocytic
receptors, megalin, and cubilin. In vitro experiments
supported the in vivo observations. The findings suggest that
L-lysine may affect receptor trafficking in addition to possible
effects on the direct binding of ligands to the receptors.
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Tubular uptake of filtered protein is mediated by pro-
ximal tubule endocytosis. This process involves the initial
binding to endocytic receptors at the luminal surface of
the proximal tubule cells. Previous studies have established
two multiligand receptors, megalin and cubilin, as respon-
sible for the endocytic uptake of a large number of different
proteins and peptides, including lipoproteins, hormones,
nutrients, and enzymes.1,2 Both receptors are heavily
expressed at the luminal surface of proximal tubule cells
and other absorptive epithelia, including yolk sac epi-
thelial cells. Inhibition of proximal tubule reabsorption of
proteins is an important experimental approach for the
study of glomerular permeability and tubular function. Also
inhibition of renal uptake has been introduced to protect
the kidney from filtered, nephrotoxic agents, for example
radiolabeled peptides and antibody fragments used experi-
mentally as targeted anti-cancer drugs.3–9 Basic amino
acids, notably L-lysine, inhibit the reabsorption of proteins
in the proximal tubule whereas neutral or acidic amino acids
do not.10,11 Inhibition of proximal tubule endocytosis of
plasma proteins and peptides by L-lysine infusion has been
evaluated in several experimental studies12–14 primarily
based on analysis of the excretion of specific proteins in the
urine.
The present study characterizes a new model of
orally administered L-lysine to inhibit tubular protein uptake.
We have characterized the effect of L-lysine treatment on
tubular protein handling by comparing, qualitatively and
quantitatively, the urinary protein excretion and cellular
uptake of selected, endogenous proteins, including albumin,
vitamin D-binding protein (DBP), retinol-binding protein
(RBP), transferrin, and b2-microglobulin. Urinary protein
excretion was characterized by one- and two-dimensional
gel electrophoresis, immunoblotting, and radioimunoassay
whereas tubular uptake of proteins and receptor expres-
sion were analyzed by immunocytochemistry. Futher-
more, megalin- and cubilin-expressing yolk sac BN16 cells
were exposed to L-lysine and the effects on albumin
endocytosis and the expression of endocytic receptors were
analyzed.
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RESULTS
Oral L-lysine treatment
Rats generally tolerated oral L-lysine treatment although
one L-lysine-treated rat was excluded after 24 h of L-lysine
treatment because of diarrhea. One rat exhibited heavy
proteinuria prior to the administration of glycine and was
excluded.
Oral L-lysine treatment resulted in a significant, sixfold
increase in plasma L-lysine concentration compared to water
treated rats (Table 1) and caused a significant, 46- and 33-
fold increase in urinary L-lysine excretion after 24 and 30 h of
treatment, respectively, compared to baseline levels (Table 2).
Plasma levels of glycine were increased fivefold in the glycine-
treated rats (Table 1) resulting in a significant 12-fold
increase in urinary glycine excretion after 24 h of treat-
ment (Table 2). No significant changes in the plasma levels of
sodium, potassium, glucose, or creatinine were observed,
either in L-lysine- or glycine-treated rats. Glycine treatment
caused a significant increase in plasma urea (Table 1) and
urinary urea excretion after 24 h of treatment compared to
baseline levels (Table 2). L-Lysine treatment induced an
increase in urine output from 12.5 to 25 ml/min after 24 h
treatment (Table 2). Oral L-lysine treatment did not result in
any significant changes in the urinary excretion of sodium,
creatinine, or urea (Table 2). A urine glucose dip-stick test
was negative in all rats (Table 2). Electron microscopy of the
glomerulus and proximal tubule cells showed no ultrastructural
changes after L-lysine treatment (Figure 1a and b).
Urinary protein analysis
One-dimensional electrophoresis and silver staining of urine
from rats receiving water, glycine, or L-lysine revealed
extensive proteinuria in L-lysine-treated rats and several
protein bands were identified exclusively in urine from
L-lysine-treated rats (Figure 2, lanes 9–12). There was no
difference in urinary protein content following glycine
treatment (Figure 2, lanes 5–8) compared to water treatment
(Figure 2, lanes 1–4). Thus, in the following rats treated with
glycine will be referred to as controls.
Urine pooled from four control or four L-lysine-treated
rats was analyzed by two-dimensional gel electrophoresis
(Figure 3). Oral L-lysine treatment induced excretion of a
large variety of primarily acidic proteins (Figure 3b) not
identified in the control urine (Figure 3a). Immunoblotting
allowed the identification of several of these spots as
immunoreactive for albumin or DBP (Figure 3b) and thus
representing these proteins or fragments thereof. Haptoglo-
bin, hemopexin, and angiotensinogen were identified by mass
spectrometry (Figure 3b). None of the latter proteins have
previously been identified in L-lysine-induced proteinuria
Table 1 | Plasma analysis in rats treated orally for 30 h with
L-lysine (n=4), glycine (n=4), or water (n=5)
L-Lysine
treatment
Glycine
treatment
Water
treatment
L-Lysine (mM) 5.9271.69a 1.1670.23 0.9970.21
Glycine (mM) 0.3570.03 2.4270.50b 0.4970.09
Creatinine (mM) 42.273.59 37.872.36 36.873.42
Urea (mM) 7.9872.60 10.2070.43c 7.0270.76
Sodium (mM) 133719 155720 143711
Potassium (mM) 3.8370.40 3.7170.33 3.6870.34
Glucose (mM) 6.9470.95 9.2472.30 8.6370.76
Analyzed by one-way analysis of variance with post hoc t-test and Bonferroni
correction. Po0.05 is considered significant.
Values are expressed as mean7s.d.
aP=0.001 vs glycine treatment and P=0.0003 vs water treatment.
bP=0.0002 vs L-lysine treatment and P=0.00006 vs water treatment.
cP=0.0001 vs water treatment.
Table 2 | Results of urine analysis in rats before, after 24, and
30 h of oral treatment with L-lysine (n=4) or glycine (n=4)
L-lysine treatment
Before 0–24 h 24–30 h
Urine output (ml/min) 12.571.6 25.074.2a 18.972.2
L-Lysine (mmol/min) 0.0770.03 3.2371.23b 2.3170.88b
Glycine (mmol/min) 0.5070.21 0.2670.10 0.2070.09
Albumin (mg/min) 0.3070.18 1.0870.15c 1.7470.26d
Creatinine (nmol/min) 46.072.7 31.477.8 41.17711.9
Urea (mmol/min) 7.870.7 7.071.2 7.971.9
Sodium (mmol/min) 0.8070.13 1.4170.34 1.0470.34
Glucose Negative Negative Negative
Glycine treatment
Before 0–24 h 24–30 h
Urine output (ml/min) 12.274.2 14.774.6 13.575.3
L-Lysine (mmol/min) 0.0670.03 0.0870.06 0.0370.02
Glycine (mmol/min) 0.4570.14 5.6171.20e 2.1471.37
Albumin (mg/min) 0.4970.25 0.5170.24 0.4370.26
Creatinine (nmol/min) 48.976.3 44.375.5 58.7712.3
Urea (mmol/min) 9.071.5 11.972.1f 13.273.5
Sodium (mmol/min) 0.9470.19 0.8470.24 0.9670.33
Glucose Negative Negative Negative
Values are expressed as mean7s.d.
P-values vs before treatment: aP=0.009; bP=0.014; cP=0.0001; dP=0.005; eP=0.004;
fP=0.006.
Analyzed by one-way ANOVA with post hoc paired t-test and Bonferroni’s correction.
Po0.05 is considered significant.
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Figure 1 | Renal ultrastructure following oral L-lysine treatment.
(a) Electron micrographs of glomerular basement membrane, and
(b) proximal tubule cell from rat treated with L-lysine for 30 h. (a) An
intact filtration barrier can be identified including fenestrations of the
endothelium (white arrowhead), an intact basement membrane
(white arrow), and filtration slits (black arrowhead) between the foot
processes of the podocyte (black arrows). (b) The ultrastructure of the
proximal tubule cell also appears normal with endocytic vacuoles
(black arrows), dense apical tubules (black arrowheads), and tight
junction (white arrowhead). BB: brush border; M: mitochondria. Bars
equal 1 mm.
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and the presence of haptoglobin was confirmed by non-
reducing sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and immunoblotting showing two bands
of approximately 124 and 100 kDa (Figure 4a, lanes 5–8),
corresponding to the two forms of this protein secreted by the
rat liver.15 In addition, one-dimensional gel electrophoresis and
immunoblotting showed an increased excretion of specific
proteins including transferrin (Figure 4b), DBP (Figure 4c),
RBP (Figure 4d), and b2-microglobulin (data not shown).
Urinary albumin excretion, quantified by radioimmu-
noassay, revealed a four- and sixfold increase after 24 and
30 h of L-lysine treatment, respectively (Table 2). No increase
in the albumin excretion rate was seen in the control rats
when compared to water treated rats. Additional acidic,
low molecular weight proteins were found in both control
and L-lysine-treated rat urine (Figure 3a and b). These
were identified by mass spectrometry as rat urinary protein
1 and 2.
Protein uptake in proximal tubule and BN16 cells
The tubular accumulation of albumin, b2-microglobulin,
RBP, DBP, and transferrin was examined by immunocyto-
chemistry. While intense proximal tubule vesicular labeling
reflecting albumin endocytosis was observed in control rats
(Figure 5a), virtually no intracellular albumin labeling was
identified in the L-lysine-treated rat (Figure 5b) indicating a
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Figure 3 | Two-dimensional reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining of
urine pooled from (a) four glycine, and (b) four L-lysine treated rats. A number of protein spots apparent in the urines from L-lysine-treated
rats could not be identified in the control urines. A fraction of these were identified by immunoblotting as intact or fragments of albumin, DBP,
and haptoglobin, and by mass spectrometry as haptoglobin, hemopexin, and angiotensinogen. A group of low molecular weight proteins were
excreted in unaltered or decreased amounts in the urines of L-lysine-treated rats. Two of these were identified by mass spectrometry as rat
urinary protein 1 and 2.
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Figure 4 | Non-reducing sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and immunoblotting of urines
from (lanes 1–4) glycine and (lanes 5-8) L-lysine-treated rats. The
urine volume loaded from each rat was corrected proportionally to
the differences in urinary output from each rat. Increased excretion of
(a) haptoglobin, (b) transferrin, (c) vitamin D-binding protein (DBP),
and retinol-binding protein (RBP) (d) was observed in L-lysine-treated
rats.
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Figure 2 | Urinary protein excretion following oral L-lysine
treatment. Urines from rats treated with (lanes 1–4) water, (lanes 5–8)
glycine, and (lanes 9–12) L-lysine subjected to non-reducing 12%
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) followed by silver staining. A clearly increased excretion of
proteins is observed in urine from rats treated with L-lysine compared
to glycine and water treatment. Some of these proteins are identified
in Figures 3 and 4. No apparent difference in the urinary protein
excretion was found in urine from glycine-treated rat compared to
water treatment. The amount of urine loaded from each rat is
adjusted proportionally to the rat with the highest urinary output.
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strong inhibition of albumin uptake. Only a partial inhibition
of proximal tubule accumulation of b2-microglobulin (Figure
5c and d), DBP, and transferrin (data not shown), and no
obvious changes in labeling of RBP (Figure 5e and f) were
observed despite the documented increase in the urinary
excretion of these proteins.
Uptake of radiolabeled rat albumin in BN16 cells
incubated with L-lysine was significantly reduced by 80%
while glycine did not affect albumin uptake (Figure 6a). To
test whether the inhibitory effect of L-lysine was reversible
cells were preincubated with L-lysine and allowed to recover
for 2 h before incubation with 125I-albumin resulting in a
complete normalization of albumin endocytosis (Figure 6b).
Receptor expression
Immunocytochemistry using antibodies against megalin
(Figure 7a and b) and cubilin (Figure 7c and d) revealed
an increased apical immunoreactivity in proximal tubules
from L-lysine-treated rats (Figure 7b and d) compared to
controls (Figure 7a and c). In control rats labeling for
megalin (Figure 7a) and cubilin (Figure 7c) was localized
along the base of the brush border as normally observed in
segment S1 rat proximal tubules while in the L-lysine-treated
rats a consistent and intense receptor-labeling extending to
the tip of the brush border was identified in all proximal
tubule profiles (Figure 7b and d). Furthermore, immuno-
blotting revealed an increased urinary excretion of the
cubilin receptor in L-lysine-treated rats (Figure 8a, lanes
5–8) compared to controls (Figure 8a, lanes 1–4). Megalin
fragments, but not intact megalin, were identified in the
a b
c d
e f
Figure 5 | Immunocytochemistry on sections from kidney cortex
from (a, c, and e) glycine and (b, d, and f) L-lysine treated rats.
Sections incubated with anti-albumin antibodies (1:160 000) revealed
abundant vesicular accumulation in the (a) control rat reflecting
endocytosis, whereas virtually no albumin could be identified
in sections from the (b) L-lysine-treated rat. Antibodies against
b2-microglobolin (1:200) revealed a decreased labeling in the
(d) L-lysine-treated rat compared to the (c) control. Sections treated
with antiretinol-binding protein (RBP) antibodies (1:16 000) revealed
no apparent difference in labeling between (e) control and
(f) L-lysine-treated rat. Original magnification  900.
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Figure 6 | Uptake of 125I-albumin by rat yolk sac BN16 cells.
(a) Cells were incubated for 6 h with (m) medium, (’) þ 10 mM
L-lysine, or (n) þ 10 mM glycine, and then supplemented with
radiolabeled albumin for 2 h. Data are means of n¼ 4 experiments. s.d.
are indicated. *Indicates Po0.05 vs control and glycine. (b) Cells were
incubated with medium throughout the experiment (m) or pre-
incubated for 6 h with mediumþ 10 mM L-lysine, then supplemented
with radiolabeled albumin for another 2 h in the (’) presence or (n)
absence of L-lysine. The cells incubated in the absence of L-lysine were
allowed a 2 h recovery period without L-lysine before exposure to
radiolabeled protein. Data are means of n¼ 3 or 4 experiments. s.d.
are indicated. *Indicates Po0.05 vs control and L-lysine7.
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Figure 7 | Immunofluorescence microscopy of kidney cortex
sections labeled with antibodies directed against (a and b)
megalin (1:20 000), or (c and d) cubilin (1:5000). In glycine-treated
rats (a) megalin and (c) cubilin were localized at the base of the S1
proximal tubule brush border whereas L-lysine treatment was
associated with an intense brush border labeling for both (b) megalin
and (d) cubilin which extended to the tip of the microvilli in all
tubular profiles. Original magnifications: (a and b)  550;
(c and d):  1250.
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urine of both control and L-lysine-treated rats (data not
shown). BN16 cells incubated with L-lysine revealed no
change in megalin or cubilin expression levels (Figure 8b) as
well as no change in lactate dehydrogenase (LDH) activity in
the medium (Figure 8c) when incubated for up to 24 h with
low doses of L-lysine (10 mM) comparable to the concentra-
tion in plasma of L-lysine-treated rats. At higher concentra-
tions a decrease in megalin and cubilin expression and an
increase in LDH activity in the medium were observed after
24 h (Figure 8b and c).
DISCUSSION
The present study characterizes the induction of proteinuria
in rats by oral L-lysine treatment. Two-dimensional gel
electrophoresis revealed a large number of proteins and
protein fragments excreted in excessive amounts in rats
treated orally with L-lysine. A number of these proteins were
identified by immunoblotting or mass spectrometry includ-
ing albumin, transferrin, DBP, RBP, b2-microglobulin, hapto-
globin, hemopexin, and angiotensinogen, several of which are
known ligands to the proximal tubule endocytic receptors
megalin or cubilin.
Intravenously infused L-lysine has been frequently used in
order to inhibit tubular uptake of proteins11–13,16 and radio-
labeled compounds used in experimental cancer therapy.6–8
The use of intravenous infusion requires venous catheteriza-
tion limiting the time for which this can be applied.
In addition, bladder catheterization is often used for urine
collection. In our hands, as well as others, this procedure
has caused difficulties in the analysis of urinary proteins
since minimal damage to the urinary tract epithelial cells
may cause leak of interstitial and/or plasma proteins.16
In our preliminary studies, using i.v. L-lysine, anesthesia,
and bladder catheterization, baseline albumin concentra-
tions prior to treatment were 12-fold higher than in non-
catheterized animals most likely due to epithelial damage
caused by the catheter.
In the present study, one rat was excluded due to diarrhea.
Whether this was a result of L-lysine treatment is unresolved,
however, there was no evidence of major electrolyte distur-
bances in the remaining L-lysine treated rats. Oral L-lysine
was significantly absorbed to produce a sixfold increase in
plasma-L-lysine concentration and proved as efficient as i.v.
L-lysine in producing albuminuria causing a sixfold increase
in albumin excretion rate after L-lysine treatment similar to
previous findings (four- to sixfold increases) when L-lysine
was given intravenously.12,16 No changes in the ultrastructure
of the proximal tubule were observed as a result of L-lysine
treatment. Also, no changes in renal excretion of sodium
and glucose were identified suggesting that tubular func-
tion otherwise was unaffected. This was supported by
the observation that LDH release into the medium was
unchanged when BN16 cells were incubated with comparable
concentrations (10 mM) of L-lysine.
The effect of L-lysine treatment on urinary albumin
excretion has previously been described,11,12,16 however, the
mechanism for the increased excretion is largely unknown.
Based on urinary excretion patterns11 and analysis on
glomerular structure12 it is generally believed that L-lysine
exerts an effect on tubular reabsorption. Analysis of the
proximal tubule endocytic uptake of filtered proteins by
immunocytochemistry following L-lysine treatment revealed
an almost absent labeling for albumin, a reduced labeling
for transferrin, DBP, and b2-microglobulin, however, little
or no change in accumulation of RBP, suggesting a differen-
tial effect on the uptake and degradation of different filtered
proteins. Except for angiotensinogen, haptoglobin, and
hemopexin all proteins identified as excreted in increased
amounts in the urine from L-lysine-treated rats are known
ligands to megalin and/or cubilin.17–22 The receptors
colocalize in the apical endocytic apparatus of the proximal
tubule cell and are responsible for the tubular reabsorption of
a variety of filtered proteins.2 Interestingly, the L-lysine-
induced proteinuria and decreased tubular accumulation of
protein were accompanied by a redistribution of the receptors
as indicated by an increase in the brush border receptor
immunoreactivity as well as an increased excretion of cubilin
to the urine. BN16 cells, known to internalize several of
the proteins studied, that is, transferring,22 DBP,20 and RBP,17
by a megalin and cubilin-mediated mechanism, revealed a
very efficient L-lysine-induced inhibition of albumin endo-
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Figure 8 | Effect of L-lysine on receptor expression and urinary
excretion. (a) Non-reducing sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) and immunoblotting of urine from
(lanes 1–4) glycine and (lanes 5–8) L-lysine-treated rats using anti-
cubilin antibodies. L-Lysine treatment resulted in an increased
excretion of the cubilin receptor and fragmented cubilin in the urine
whereas only weak bands could be detected in control urine. The
urine volume loaded from each rat was corrected proportionally to
the urinary output. (b) Non-reducing SDS-PAGE and immunoblotting
for megalin or cubilin on 5 mg per lane of homogenized BN16 cells
incubated for 8 or 24 h with glycine (lane 1: 10 mM, 2: 25 mM, 3: 50 mM)
or L-lysine (lane 4: 10 mM, 5: 25 mM, 6: 50 mM). At 8 h no changes in
total immunoreactive megalin or cubilin expression was observed in
cells incubated with L-lysine as compared to glycine. At 24 h no
change was observed at 10 mM L-lysine while at higher concentra-
tions megalin and cubilin expression decreased compared to cells
incubated with similar concentrations of glycine. (c) LDH activity in
the incubation medium from BN16 cells incubated for 8 or 24 h with
10, 25, or 50 mM of glycine or L-lysine (n¼ 1). Only the high
concentrations of L-lysine for 24 h induced a marked increase in
LDH-release to the incubation medium.
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cytosis as in the in vivo model, but showed no change in total
immunoreactive receptor protein levels. This suggests that
the luminal accumulation of receptors observed in vivo is the
result of altered trafficking rather than a change in total
protein levels. Cubilin, having no transmembrane domain,
is loosely associated with the plasma membrane and may be
released by nonenzymatic and nonsolubilizing procedures.23
It is possible that L-lysine causes a similar release of receptor
protein. In addition to effects on receptor trafficking L-lysine
may also directly inhibit binding of filtered proteins to
ligand binding areas on the receptors. This is supported
by the finding that basic amino-acid residues in the ligand
are important for binding to megalin.24 Finally, it cannot be
excluded that the osmotic load induced by the highly
increased filtration of L-lysine and possibly chloride may
exert an effect on tubular function, including the induction
of polyuria observed in the L-lysine-treated rats. Oral L-lysine
treatment did not result in any significant reduction in
glomerular function as reflected by the plasma and urinary
levels of creatinine. Furthermore, L-lysine treatment did not
alter the ultrastructural appearance of the glomerular
filtration barrier. In the present study, we observed an
increased excretion of higher molecular weight proteins like
transferrin (80 kDa), hemopexin (85 kDa), and haptoglobin
(96 kDa). Despite its relatively large size transferrin has
recently been found to be a ligand for the cubilin receptor,22
and in the present study an increase in the urinary excretion
of transferrin was associated with decreased proximal tubule
accumulation. The presence of haptoglobin and hemopexin
in the urine of L-lysine-treated rats suggests that larger
proteins may be filtered or that L-lysine may have some
additional effects on glomerular permeability.
Although the urinary excretion of the vast majority of
analysed proteins increased with L-lysine treatment this
was not the case with rat urinary protein 1 and 2 which
were unaltered or decreased. Rat urinary protein 1 and 2 are
believed to be liver-specific proteins that are filtered and
excreted in normal rat urine in high amounts.25 Apparently
these proteins are not reabsorbed in the proximal tubule.
In conclusion, oral L-lysine treatment, requiring no inva-
sive procedures, causes marked proteinuria and is as efficient
as intravenous infusion in producing albuminuria. A number
of different proteins were identified in the urine of L-lysine-
treated rats. Despite an increase in the urinary excretion of
these proteins the apparent effect of L-lysine on tubular protein
accumulation was variable suggesting differential effects on
tubular reabsorption and degradation of filtered proteins.
Finally, L-lysine-induced changes in the immunolocalization of
the endocytic receptors megalin and cubilin suggest that
L-lysine may affect receptor trafficking in addition to possible
effects on the direct binding of ligands to the receptors.
MATERIALS AND METHODS
Animal model
Fifteen female Wistar rats (Taconic M&B, Ejby, Denmark) weighing
210–230 g were placed in metabolic cages with free access to standard
rat diet and water. Urine was collected during a period of 24 h to
obtain baseline levels. The rats were divided into three groups
receiving a solution of either 4.5 mmol L-lysine monohydrochloride
(Merck, Darmstadt, Germany) (n¼ 5), 4.5 mmol glycine (Sigma-
Aldrich, St Louis, MO, USA) (n¼ 5), or water (n¼ 5) administered
through a gastric feeding tube every 6th hour for a total of 30 h.
L-lysine and glycine were dissolved in 2.4 ml of tap water and
adjusted to pH 7.4. During the 30 h of exposure urine was collected
during an initial 24 h equilibration period followed by a 6 h
experimental period. The urines were centrifuged at 4000 g for
10 min and stored at 201C. All tubes used for urine collection were
coated using a 2% Tween solution before use. At the end of the
experiment rats were anesthetized with sodium pentothal and blood
was drawn from the femoral vein. The heparinized blood samples
were centrifuged and plasma was stored at 201C. The kidneys were
perfusion fixed through the abdominal aorta with 2% paraformal-
dehyde in 0.1 M cacodylate buffer, pH 7.4 and postfixed in the same
fixative for 1 h at 41C. Small tissue blocks were prepared from cortex
and infiltrated in 2.3 M sucrose in 0.01 M phosphate-buffered saline,
pH 7.4, for 30 min and frozen in liquid nitrogen. All animal
experiments were carried out in accordance with provisions for the
animal care license provided by the Danish National Animal
Experiments Inspectorate.
Quantitative urine and plasma analyses
The urinary albumin concentration was measured by radioimmu-
noassay. Diluted urine samples were incubated with rabbit anti-rat
albumin (Nordic Immunological, Tilburg, The Netherlands) and
iodinated rat albumin for 48 h. Polyethylene glycol was used to
separate free and antibody-bound iodinated rat albumin as
described previously.26 Rat albumin (Sigma-Aldrich) was used for
iodination and calibration. Urinary creatinine was determined by
the standard Jaffe reaction. Urinary sodium and urea concentrations
were determined by a standard, automated assay. Urinary glucose
levels were estimated using Combur test strips (Roche A/S,
Hvidovre, Denmark). The plasma and urine concentrations of
L-lysine and glycine were measured by HPLC (Kontron Instruments,
Milan, Italy) with precolumn o-phthalaldehyde derivatization and
fluorescence detection as described previously.27
Antibodies
The following polyclonal antibodies were used for immunocyto-
chemistry and immunoblotting: Rabbit anti-human RBP and rabbit
anti-human DBP (DAKO A/S, Glostrup, Denmark); goat anti-
mouse b2-microglobulin (Research Diagnostics Inc., Flanders, NJ,
USA); sheep anti-rat albumin (Biogenesis, Poole, UK); goat anti-
human haptoglobin (Sigma-Aldrich); sheep anti-rat megalin28; and
rabbit anti-rat cubilin.29 Peroxidase-conjugated secondary anti-
bodies were purchased from DAKO. Fluorescence-conjugated
secondary antibodies were purchased from Molecular Probes
(Eugene, OR, USA). Controls for unspecific binding were performed
with nonspecific rabbit, goat, or sheep IgG (DAKO).
Light and electron microscope immunocytochemistry
For light microscopy semithin (0.8 mm) cryosections were sectioned
at 801C on a FCS Reichert ultramicrotome and preincubated with
0.01 M phosphate-buffered saline, 1% BSA, or 0.1% milk, 0.05 M
glycine, pH 7.4, followed by incubation with primary antibodies for
1 h and peroxidase or fluorescence-conjugated secondary antibodies
for 1 h at room temperature. The peroxidase was visualized by
incubation with diaminobenzidine and 0.03% H2O2. Sections were
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counterstained with Meiers hematoxilin and examined in a light
microscope (Leica DMR) equipped with a color video camera (Sony
3CCD) or a Leica SP2 confocal microscope.
For electron microscopy frozen kidney tissue blocks were
cryosubstituted as described previously17 and 50 nm sections were
cut on a FCS Reichert ultramicrotome and observed in a Philips
CM100 electron microscope.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
and immunoblotting
Urine samples were diluted in non-reducing Laemmli buffer30 and
separated by electrophoresis, using 12, 15, or 3–16% polyacrylamide
gels and immunoblotted as described.31 The volume of urine from
each rat loaded onto the gel was proportional to the total urinary
output during the 6 h collection period with 10 ml loaded urine from
the rat with the highest urinary output.
Two-dimensional gel electrophoresis
Urine samples from four glycine or four L-lysine-treated rats were
pooled so that the relative volume contributions from each rat were
proportional to the urinary output during the 6 h urine collec-
tion. Urine was solubilized in 8.9 M urea, 2% Triton X-100, 2%
immobilized pH gradient (IPG) buffer (pH 3–10, nonlinear,
Pharmacia, Uppsala, Sweden), and 2% dithiothreitol. Horizontal,
isoelectric focusing was performed using an IPG. Ten ml of urine
sample was loaded to the IPG strip (Pharmacia) in a reswelling tray.
Second dimension was run vertically and the gel was silver stained
using an optimized protocol for high-sensitivity protein identifica-
tion by mass spectrometry.32 Visualized proteins were excised from
gels and identified by querying a protein sequence database with
mass spectrometric data. The analyses were performed as contract
work by Alphalyse A/S (Odense, Denmark). Silver stained and
excised proteins were digested using the protocol essentially as
described by Shevchenko et al.33 Small aliquots of the generated
peptide mixtures were analyzed by MALDI mass spectrometry on a
REFLEX III instrument (Bruker Daltonik, Bremen, Germany). The
peptide masses obtained by MALDI MS were used to query the
nonredundant protein database run by EMBL/EBI.
Cell culture experiments
Rat yolk sac carcinoma BN16 cells29 were cultured in DMEM/L-
glutamine (Bio-Whittaker, Walkersville, MD, USA) supplemented
with 10% fetal calf serum, 50 U/ml penicillin, and 50mg/ml
streptomycin at 371C, 5% CO2. For receptor expression experiments
the confluent cell layers in 75-cm2 plastic culture flasks (Corning
Costar, Badhoevedrop, Holland) were incubated for 8 or 24 h in
medium as described above containing 10, 25, or 50 mM of L-lysine
or glycine. The LDH activity in the recovered medium was measured
using a LDH Optimized kit34 (Sigma-Aldrich) according to
manufacturer’s instructions. Cells were washed times three in
phosphate-buffered saline, detached in 10 ml of dissection buffer
(0.3 M sucrose, 25 mM imidazole, 1 mM EDTA, 8.5 mM leupeptin,
1 mM phenylmethylsulfonyl fluoride, pH 7.2) using a cell scraper,
centrifuged at 4000 g for 5 min, reconstituted in 500 ml of dissection
buffer, and homogenized using a T8 homogenizer (IKA Labortech-
nik, Staufen, Germany) at maximum speed for 30 s. The
homogenates were centrifuged at 1000 g for 15 min followed by
collection of the supernatant. Five mg of supernatant were subjected
to SDS-PAGE followed by western blotting as described above using
antibodies against megalin and cubilin. Protein concentrations were
measured using the Bradford method.35
For 125I-albumin uptake studies cells were incubated in 24-well
plates (Corning Inc, NY, USA) with 10 mM L-lysine (n¼ 4), 10 mM
glycine (n¼ 4), or buffer alone (n¼ 4) for 5 h and 30 min followed
by 30 min incubation with serum free medium containing 0.5%
ovalbumin (Sigma-Aldrich) and amino acids as described. Cells
were subsequently incubated with 125I-albumin (8000 c.p.m. per
well, iodinated using the chloramine-T method as described36) for
30, 60, or 120 min. Medium was collected and cells were washed
twice in phosphate-buffered saline, 1% BSA and detached with 0.1 M
NaOH. Medium was precipitated with 10% trichloroacetic acid
(TCA). The activity of the precipitate, supernatant, and cells was
counted separately in a Packard Cobra 5002 gamma-counter. The
amount of degraded 125I-albumin was estimated as non-TCA
precipitated activity in the medium corrected for the non-TCA
precipitated activity in the medium of wells incubated similarly but
without cells. Total uptake of 125I-albumin was calculated as the sum
of cell-associated activity and degraded 125I-albumin in the medium
and expressed in percent of total activity added. An additional
L-lysine inhibition experiment was performed as described except
for the introduction of 2 h of L-lysine free incubation to allow cells
to recover prior to addition of 125I-albumin.
Statistics
All data are presented as mean7s.d. Statistical analysis on in vivo
and in vitro data was performed using one-way analysis of variance
followed by Student’s t-test or paired t-test with Bonferroni’s
correction to test for differences between the groups and time
points. A P-value o0.05 is considered significant.
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